Preeclampsia is one of the most severe gestational complications which is one
of the leading causes of maternal and perinatal morbidity and mortality. A
growth in the incidence of severe and combined forms of the pathology has been
observed in recent years. According to modern concepts, inadequate
cytotrophoblast invasion into the spiral arteries of the uterus and development
of the ischemia-reperfusion syndrome in the placental tissue play the leading
role in the development of preeclampsia, which is characterized by
multipleorgan failure. In this regard, our work was aimed at studying the
patterns of placental tissue transcriptome that are specific to females with PE
and with physiological pregnancy, as well as identifying the potential
promising biomarkers and molecular mechanisms of this pathology. We have
identified 63 genes whose expression proved to differ significantly in the
placental tissue of females with PE and with physiological pregnancy. A cluster
of differentially expressed genes (DEG) whose expression level is increased in
patients with preeclampsia includes not only the known candidate genes that
have been identified in many other genome-wide studies (e.g.,
LEP, BHLHB2, SIGLEC6,
RDH13, BCL6), but also new genes
(ANKRD37, SYDE1, CYBA,
ITGB2, etc.), which can be considered as new biological
markers of preeclampsia and are of further interest. The results of a
functional annotation of DEG show that the development of preeclampsia may be
related to a stress response, immune processes, the regulation of cell-cell
interactions, intracellular signaling cascades, etc. In addition, the features
of the differential gene expression depending on preeclampsia severity were
revealed. We have found evidence of the important role of the molecular
mechanisms responsible for the failure of immunological tolerance and
initiation of the pro-inflammatory cascade in the development of severe
preeclampsia. The results obtained elaborate the concept of the pathophysiology
of preeclampsia and contain the information necessary to work out measures for
targeted therapy of this disease. ;